Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 23, 2022

Accession no.
0001209191-22-062641
Filed
Dec 23, 2022
Trade date
Nov 1-30, 2022
Filing delay
52 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.23K. It was filed 52 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2022Common StockPPurchaseAcquired+105$2.53+$265.65199,805Direct
Nov 2, 2022Common StockPPurchaseAcquired+105$2.54+$266.7199,910Direct
Nov 3, 2022Common StockPPurchaseAcquired+105$2.44+$256.2200,015Direct
Nov 4, 2022Common StockPPurchaseAcquired+105$2.42+$254.1200,120Direct
Nov 7, 2022Common StockPPurchaseAcquired+105$2.45+$257.25200,225Direct
Nov 8, 2022Common StockPPurchaseAcquired+105$2.42+$254.1200,330Direct
Nov 9, 2022Common StockPPurchaseAcquired+105$2.37+$248.85200,435Direct
Nov 10, 2022Common StockPPurchaseAcquired+105$2.37+$248.85200,540Direct
Nov 11, 2022Common StockPPurchaseAcquired+105$2.32+$243.6200,645Direct
Nov 14, 2022Common StockPPurchaseAcquired+105$2.32+$243.6200,750Direct
Nov 15, 2022Common StockPPurchaseAcquired+105$2.35+$246.75200,855Direct
Nov 16, 2022Common StockPPurchaseAcquired+105$2.31+$242.55200,960Direct
Nov 17, 2022Common StockPPurchaseAcquired+105$2.29+$240.45201,065Direct
Nov 18, 2022Common StockPPurchaseAcquired+105$2.27+$238.35201,170Direct
Nov 21, 2022Common StockPPurchaseAcquired+105$2.38+$249.9201,275Direct
Nov 22, 2022Common StockPPurchaseAcquired+105$2.37+$248.85201,380Direct
Nov 23, 2022Common StockPPurchaseAcquired+105$2.29+$240.45201,485Direct
Nov 25, 2022Common StockPPurchaseAcquired+105$2.31+$242.55201,590Direct
Nov 28, 2022Common StockPPurchaseAcquired+105$2.37+$248.85201,695Direct
Nov 29, 2022Common StockPPurchaseAcquired+105$2.34+$245.7201,800Direct
Nov 30, 2022Common StockPPurchaseAcquired+105$2.32+$243.6201,905Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)